Access

Business

Nature 446, 125 (8 March 2007) | doi:10.1038/446125a; Published online 7 March 2007

Open Innovation Challenges

naturejobs

In brief

The US Food and Drug Administration is set to approve the first vaccine for use in an avian flu pandemic. An advisory committee said the regulator should approve the vaccine, made by Sanofi-Pasteur, the vaccine arm of Paris-based Sanofi-Aventis.